Fidelity National Financial, Inc. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$151.2M
Insider Sells Quantity
15
Insider Sells Sum
$200,099.70

Insider Activity of Fidelity National Financial, Inc.

Biography of Fidelity National Financial, Inc.

No biography is available at this moment.

2025-03-24PurchaseF&G Annuities & Life, Inc.
FG
10 percent owner
4.5M
3.4371%
$33.60$151.2M-7.89%
2009-08-19SaleEterna Therapeutics Inc.
ERNA
10 percent owner
400,000
0.4214%
$0.23$92,000+58.82%
2009-08-04SaleEterna Therapeutics Inc.
ERNA
10 percent owner
8,400
0.0137%
$0.36$2,984+68.75%
2009-07-30SaleEterna Therapeutics Inc.
ERNA
10 percent owner
4,400
0.0071%
$0.35$1,540+63.64%
2009-07-29SaleEterna Therapeutics Inc.
ERNA
10 percent owner
60,000
0.0853%
$0.31$18,630+68.75%
2009-07-28SaleEterna Therapeutics Inc.
ERNA
10 percent owner
108,000
0.1572%
$0.32$34,322+68.75%
2009-07-27SaleEterna Therapeutics Inc.
ERNA
10 percent owner
65,000
0.0923%
$0.31$20,150+74.19%
2009-07-23SaleEterna Therapeutics Inc.
ERNA
10 percent owner
37,300
0.0599%
$0.35$13,083+58.82%
2009-07-17SaleEterna Therapeutics Inc.
ERNA
10 percent owner
300
0.0005%
$0.37$111+54.29%
2009-07-15SaleEterna Therapeutics Inc.
ERNA
10 percent owner
400
0.0007%
$0.39$156+50%
2009-07-14SaleEterna Therapeutics Inc.
ERNA
10 percent owner
2,100
0.0038%
$0.39$819+42.11%
2009-07-13SaleEterna Therapeutics Inc.
ERNA
10 percent owner
7,900
0.0144%
$0.40$3,143+38.46%
2009-07-10SaleEterna Therapeutics Inc.
ERNA
10 percent owner
2,000
0.0036%
$0.39$780+35%
2009-07-09SaleEterna Therapeutics Inc.
ERNA
10 percent owner
2,000
0.0036%
$0.39$780+35%
2009-07-01SaleEterna Therapeutics Inc.
ERNA
10 percent owner
10,000
0.0216%
$0.47$4,726+14.89%
2009-06-30SaleEterna Therapeutics Inc.
ERNA
10 percent owner
15,000
0.0315%
$0.46$6,876+17.39%
Total: 16
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.